These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 15955372
21. Preoperative hypoglycemia in a patient receiving insulin detemir. Olson RP, Bethel MA, Lien L. Anesth Analg; 2009 Jun; 108(6):1836-8. PubMed ID: 19448209 [Abstract] [Full Text] [Related]
22. Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine. Janka HU. Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():35-41. PubMed ID: 18577155 [Abstract] [Full Text] [Related]
26. Combination therapy with new targets in Type 2 diabetes: a review of available agents with a focus on pre-exercise adjustment. McDonnell ME. J Cardiopulm Rehabil Prev; 2007 Jul; 27(4):193-201. PubMed ID: 17667012 [Abstract] [Full Text] [Related]
27. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study. Gao Y, Guo XH, Vaz JA, PRESENT Study Group. Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806 [Abstract] [Full Text] [Related]
28. Insulin in type 2 diabetes: promises to keep. Basu AK, Bandyopadhyay D, Bandyopadhyay R, Majumdar D, Chakrabarty PP. J Indian Med Assoc; 2004 Aug; 102(8):438, 440, 442 passim. PubMed ID: 15719806 [Abstract] [Full Text] [Related]
29. Does insulin detemir have a role in reducing risk of insulin-associated weight gain? Hermansen K, Davies M. Diabetes Obes Metab; 2007 May; 9(3):209-17. PubMed ID: 17391147 [Abstract] [Full Text] [Related]
30. Insulin aspart: a review. Owens D, Vora J. Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395 [Abstract] [Full Text] [Related]
31. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs. Yang W, Ji Q, Zhu D, Yang J, Chen L, Liu Z, Yu D, Yan L. Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073 [Abstract] [Full Text] [Related]
32. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients]. Li M, Zhou J, Bo YQ, Lu W, Jia WP, Xiang KS. Zhonghua Yi Xue Za Zhi; 2008 Jun 24; 88(24):1679-82. PubMed ID: 19024537 [Abstract] [Full Text] [Related]
33. Individualizing care with injectable glucose-lowering agents. Miller EM. J Fam Pract; 2013 Dec 24; 62(12 Suppl CME):S12-9. PubMed ID: 24340344 [Abstract] [Full Text] [Related]
34. [Insulin and weight gain: myth or reality?]. Larger E, Rufat P, Dubois-Laforgue D, Ledoux S. Diabetes Metab; 2001 Nov 24; 27(5 Pt 3):S23-7. PubMed ID: 11910976 [Abstract] [Full Text] [Related]
35. Diabetes mellitus: pathogenesis and treatment strategies. Skyler JS. J Med Chem; 2004 Aug 12; 47(17):4113-7. PubMed ID: 15293979 [Abstract] [Full Text] [Related]
36. [Type 2 diabetes: hypoglycemia risk, weight gain... Will there soon be a new alternative to insulin?]. MMW Fortschr Med; 2006 Sep 14; 148(37):54. PubMed ID: 17036907 [No Abstract] [Full Text] [Related]
37. Tamsulosin and hyperglycaemia in patients with diabetes. Borgsteede S, Bruggeman R, Hoefnagel R, Huiskes M, van Puijenbroek E. Neth J Med; 2010 Mar 14; 68(3):141-3. PubMed ID: 20308713 [No Abstract] [Full Text] [Related]
38. [Drug-induced hypoglycemia]. Hashiramoto M, Kaku K. Nihon Rinsho; 2007 Oct 28; 65 Suppl 8():575-83. PubMed ID: 18074605 [No Abstract] [Full Text] [Related]
39. Diabetes: signs, symptoms and making a diagnosis. Burden M. Nurs Times; 2007 Oct 28; 99(1):30-2. PubMed ID: 12593282 [Abstract] [Full Text] [Related]
40. When oral agents fail: practical barriers to starting insulin. Korytkowski M. Int J Obes Relat Metab Disord; 2002 Sep 28; 26 Suppl 3():S18-24. PubMed ID: 12174319 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]